guidelines:
  1: Multiple_Myeloma_Response_Criteria.v1
test_cases:
- id: Test default action
  input:
    1: {}
  expected_output:
    1:
      gt0018|Response category: "local::at0043|Stable disease (SD)|"
- id: Test 'Stringent complete response'
  input:
    1:
      gt0003|Negative immunofixation of serum and urine AND disappearance of any soft tissue plasmacytomas AND <5% plasma cells in bone marrow: local::at0006|No|
      gt0004|Criteria above plus normal FLC ratio (0.26-1.65) AND absence of clonal cells in bone marrow by immunohistochemistry or immunofluorescence: local::at0005|Yes|
  expected_output:
    1:
      gt0018|Response category: "local::at0040|Stringent complete response (sCR)|"
- id: Test 'Very good partial response'
  input:
    1:
      gt0003|Negative immunofixation of serum and urine AND disappearance of any soft tissue plasmacytomas AND <5% plasma cells in bone marrow: local::at0006|No|
      gt0004|Criteria above plus normal FLC ratio (0.26-1.65) AND absence of clonal cells in bone marrow by immunohistochemistry or immunofluorescence: local::at0006|No|
      gt0005|Serum and urine M component detectable by immunofixation but not on electrophoresis OR ≥90% reduction in serum M component plus urine M component <100 mg per 24 hrs: local::at0005|Yes|
  expected_output:
    1:
      gt0018|Response category: "local::at0041|Very good partial response (VGPR)|"
- id: Test 'Partial response'
  input:
    1:
      gt0003|Negative immunofixation of serum and urine AND disappearance of any soft tissue plasmacytomas AND <5% plasma cells in bone marrow: local::at0006|No|
      gt0004|Criteria above plus normal FLC ratio (0.26-1.65) AND absence of clonal cells in bone marrow by immunohistochemistry or immunofluorescence: local::at0006|No|
      gt0005|Serum and urine M component detectable by immunofixation but not on electrophoresis OR ≥90% reduction in serum M component plus urine M component <100 mg per 24 hrs: local::at0006|No|
      gt0006|≥50% reduction of serum M protein and reduction in 24 hr urinary M protein by ≥90% or to <200 mg per 24 hrs; if present at baseline, ≥50% reduction in the size of soft tissue plasmacytomas is also required: local::at0005|Yes|
  expected_output:
    1:
      gt0018|Response category: "local::at0042|Partial response (PR)|"
- id: Test 'Progressive disease'
  input:
    1:
      gt0003|Negative immunofixation of serum and urine AND disappearance of any soft tissue plasmacytomas AND <5% plasma cells in bone marrow: local::at0006|No|
      gt0004|Criteria above plus normal FLC ratio (0.26-1.65) AND absence of clonal cells in bone marrow by immunohistochemistry or immunofluorescence: local::at0006|No|
      gt0005|Serum and urine M component detectable by immunofixation but not on electrophoresis OR ≥90% reduction in serum M component plus urine M component <100 mg per 24 hrs: local::at0006|No|
      gt0006|≥50% reduction of serum M protein and reduction in 24 hr urinary M protein by ≥90% or to <200 mg per 24 hrs; if present at baseline, ≥50% reduction in the size of soft tissue plasmacytomas is also required: local::at0006|No|
      gt0007|Serum M component: 0|local::at0006|No|
      gt0008|Urine M component: 1|local::at0005|Yes|
      'gt0009|Only in patients without measurable serum and urine M protein levels: difference between involved and uninvolved FLC levels': 1|local::at0005|Yes|
      gt0010|Bone marrow plasma cell percentage: 1|local::at0005|Yes|
      gt0011|Definite development of new bone lesions or soft tissue plasmacytomas or definite increase in the size of existing bone lesions or soft tissue plasmacytomas: 1|local::at0005|Yes|
      gt0012|Development of hypercalcemia that can be attributed solely to the plasma cell proliferative disorder: 0|local::at0006|No|
  expected_output:
    1:
      gt0018|Response category: "local::at0044|Progressive disease (PD)|"
- id: Test 'Complete response'
  input:
    1:
      gt0003|Negative immunofixation of serum and urine AND disappearance of any soft tissue plasmacytomas AND <5% plasma cells in bone marrow: local::at0005|Yes|
      gt0004|Criteria above plus normal FLC ratio (0.26-1.65) AND absence of clonal cells in bone marrow by immunohistochemistry or immunofluorescence: local::at0006|No|
      gt0005|Serum and urine M component detectable by immunofixation but not on electrophoresis OR ≥90% reduction in serum M component plus urine M component <100 mg per 24 hrs: local::at0006|No|
      gt0006|≥50% reduction of serum M protein and reduction in 24 hr urinary M protein by ≥90% or to <200 mg per 24 hrs; if present at baseline, ≥50% reduction in the size of soft tissue plasmacytomas is also required: local::at0005|Yes|
      gt0007|Serum M component: 0|local::at0006|No|
      gt0008|Urine M component: 1|local::at0005|Yes|
      'gt0009|Only in patients without measurable serum and urine M protein levels: difference between involved and uninvolved FLC levels': 1|local::at0005|Yes|
      gt0010|Bone marrow plasma cell percentage: 1|local::at0005|Yes|
      gt0011|Definite development of new bone lesions or soft tissue plasmacytomas or definite increase in the size of existing bone lesions or soft tissue plasmacytomas: 1|local::at0005|Yes|
      gt0012|Development of hypercalcemia that can be attributed solely to the plasma cell proliferative disorder: 0|local::at0006|No|
  expected_output:
    1:
      gt0018|Response category: "local::at0039|Complete response (CR)|"
